Rabey Nicholas, Abood Ahid, Gillespie Patrick, Athanassoglou Vassilis, Rene Cornelius, Malata Charles M
From the Departments of *Plastic and Reconstructive Surgery and †Ophthalmology (Oculoplastic Surgery Division), Addenbrooke's University Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Ann Plast Surg. 2014 Aug;73(2):158-63. doi: 10.1097/SAP.0b013e31826a1a56.
Orbital exenteration presents a challenge to the reconstructive surgeon. Defects may be treated with split skin grafts, local advancement flaps, or free flap coverage. There are few published series showing the long-term outcomes of reconstruction. Our results, with at least a 5-year follow-up, are presented.
A retrospective review of 15 immediate reconstructions after orbital exenterations for malignancies in 12 patients at a tertiary referral center over a 5-year period, was done. All flaps were followed up for at least 5 years (mean, 75 months; range, 3-118 months).
Malignancies included squamous cell carcinoma, basal cell carcinoma, meningioma, sebaceous gland carcinoma, and rhabdomyosarcoma. Eight cervicofacial rotation-advancement flaps and 4 anterolateral thigh, 1 rectus abdominis, and 1 radial forearm free tissue transfers were used. Aggressive postoperative radiotherapy (9/15) was well tolerated by both regional and free flaps. Both cervicofacial flaps in previously irradiated patients had wound dehiscence or fistula formation. Six (50%) patients died during follow-up, 4 of whom (33%) died of tumor recurrence.
Flap reconstruction after complex orbital exenteration is associated with low morbidity. Cervicofacial rotation-advancement flaps offer reliable, single-stage, aesthetically pleasing reconstructions. They should be avoided in the previously irradiated. Free tissue transfer is indicated for volume replacement, after previous radiotherapy, after tumor recurrence and previous use of locoregional flaps. Reconstruction of complex orbital exenteration defects for malignancies should be undertaken in centers with experience in the management of these procedures.
眼眶内容剜除术给重建外科医生带来了挑战。缺损可采用中厚皮片移植、局部推进皮瓣或游离皮瓣覆盖进行治疗。很少有已发表的系列报道显示重建的长期效果。我们给出了至少随访5年的结果。
对一家三级转诊中心5年内12例患者因恶性肿瘤行眼眶内容剜除术后的15例即刻重建进行回顾性研究。所有皮瓣均随访至少5年(平均75个月;范围3 - 118个月)。
恶性肿瘤包括鳞状细胞癌、基底细胞癌、脑膜瘤、皮脂腺癌和横纹肌肉瘤。使用了8例面颈部旋转推进皮瓣、4例股前外侧皮瓣、1例腹直肌皮瓣和1例桡侧前臂游离组织移植。9例(15例中的)患者术后接受了积极放疗,区域皮瓣和游离皮瓣对此耐受性良好。先前接受过放疗的患者中,2例面颈部皮瓣均出现伤口裂开或瘘管形成。6例(50%)患者在随访期间死亡,其中4例(33%)死于肿瘤复发。
复杂眼眶内容剜除术后的皮瓣重建并发症发生率较低。面颈部旋转推进皮瓣提供可靠、单阶段、美观的重建。先前接受过放疗的患者应避免使用。游离组织移植适用于容积替代、先前放疗后、肿瘤复发后以及先前使用过局部皮瓣的情况。恶性肿瘤复杂眼眶内容剜除缺损的重建应在有这些手术管理经验的中心进行。